Notice of interruption or termination of supply of a human drug
 Date ▼HolderCodeDrugDate fromSubject
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)45894Gammanorm 165 mg/ ml (sol inj 1x10 ml (inj.liek.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)83312Octagam 10 % (sol inf 1x100 ml (fľ.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)45372Octagam (sol inf 1x20 ml (liek.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)12693Octagam (sol inf 1x200 ml (fľ.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)83310Octagam 10 % (sol inf 1x20 ml (liek.inj.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)12691Octagam (sol inf 1x50 ml (fľ.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)12692Octagam (sol inf 1x100 ml (fľ.skl.))1.6.2019R
 24.4.2019MERCK spol. s r.o. (MRS)24824Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PP/Al))23.4.2019R
 24.4.2019Merck Santé s.a.s (MES)33372Glucophage 1000 mg (tbl flm 120x1000 mg (blister PVC/Al))23.4.2019R
 24.4.2019GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)37364Voltaren Emulgel (gel 1x50 g (tuba lamin.LDPE/Al/HDPE))24.4.2019Z
 24.4.2019Wörwag Pharma GmbH & Co. KG (WGP-1)05035Benfogamma 300 (tbl flm 30x300 mg (blis.PVC/PVDC/Al))1.6.2019O
 24.4.2019sanofi-aventis groupe (SOI-1)44133TIAPRIDAL tbl (tbl 50x100 mg (blis.PVC/Al))15.5.2019R
 25.4.2019MERCK spol. s r.o. (MRS)91954Euthyrox 25 mikrogramov (tbl 100x25 µg (blis.PVC/Al))25.4.2019R
 25.4.2019Glenmark Pharmaceuticals s.r.o. (GLM-CZ)6406BBendamustine Glenmark 2,5 mg/ml (plc ifo 5x100 mg (liek.inj.skl.jantárová))26.4.2019R
 26.4.2019Mylan Ireland Limited (MNY)6238AIrbesartan/Hydrochlorothiazid Mylan 300 mg/12,5 mg (tbl 28x300 mg/12,5 mg (blis.Amber/Aclar/PVC/Al))26.4.2019R

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To